VOGLIBOSE 0.2 MG + METFORMIN HYDROCHLORIDE 500 MG SR

Product Details

VOGLIBOSE 0.2 MG + METFORMIN HYDROCHLORIDE 500 MG SR

The combination of Voglibose 0.2 mg, and Metformin Hydrochloride 500 mg SR is a medication used for the management of type 2 diabetes.

The combination is indicated for the treatment of type 2 diabetes when diet and exercise alone do not provide adequate glycemic control.

The dosage may vary, and it should be determined by a healthcare professional based on the patients individual needs and response to treatment.

Store at a controlled room temperature between 15 and 30 degrees C (59 and 86 degrees F); protect from light and moisture

Voglibose inhibits alpha-glucosidase enzymes in the small intestine, delaying the digestion and absorption of carbohydrates. This results in a reduction in postprandial blood glucose levels.

"Diarrhoea Flatulence Pneumatosis Intestinalis Abnormal Liver Function Nausea Or Vomiting Dizziness"

Use of this medicine is not recommended during pregnancies as the possible effect on developing fetus is unknown. It is recommended to discontinue the consumption of this medicine if you are pregnant or planning to become pregnant. Consult your doctor before stopping the use of this medication so that an alternate medication can be prescribed.

"Patients should be monitored regularly for signs of hypoglycemia, especially when Voglibose + Glimepiride + Metformin is used in combination with other antidiabetic medications. This medication should be used with caution in patients with renal impairment, as metformin is primarily excreted by the kidneys, and dose adjustments may be necessary to prevent adverse effects. Voglibose + Glimepiride + Metformin should not be used in patients with type 1 diabetes mellitus or diabetic ketoacidosis. Patients should be advised to adhere to a regular meal schedule and monitor blood sugar levels closely while taking this medication"

Voglibose - PubChem [Internet]. Pubchem.ncbi.nlm.nih.gov. 2021 [cited 03 December 2021]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/444020 Voglibose - DrugBank [Internet]. Drugbank.ca. 2021 [cited 3 December 2021]. Available from:

Disclaimer

At Genericart, our primary goal is to provide information that is thoroughly reviewed, accurate, and reliable. However, it is important to note that the content provided here should not be considered a substitute for professional medical advice. The information presented on our platform is intended for educational purposes only and may not cover all aspects of specific health conditions, medications, potential side effects, drug interactions, warnings, or alerts. We strongly encourage consulting with a qualified healthcare professional for advice and guidance regarding their health concerns and medication needs.